Commercial Organ Chip Platforms & Consumables
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting a requirement for the procurement of commercial microfluidic chips and proprietary consumables. This acquisition is intended to support the Center for Biologics Evaluation and Research in evaluating standardized, industry-relevant platforms that align with their strategic focus on advanced in vitro models. Classified under NAICS code 334516, this opportunity is managed by the FDA. Interested parties may coordinate through the CBER Acquisition Liaison, as the specific contracting officer is yet to be determined.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Prepare for this forecast
Research this forecast and prepare for the solicitation
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
